Condition: Intra Cerebral Hemorrhage · Sponsor: Columbia University
The objectives of the RECONFIG clinical study are to : 1. To identify the time to the first diagnosis of cognitive motor dissociation (CMD) in intracerebral hemorrhage (ICH) patients and to investigate whether these patients will clinically follow commands earlier after the hemorrhage. 2. To determine whether CMD independently predicts long term functional outcomes (6-month mRS scores) in ICH patients, and is associated with long term cognitive and quality of life outcomes. 3. To determine the EEG response to verbal commands of the motor imagery paradigm between patients with and without sensory aphasia. The overall goal is to determine predictors and the trajectory of neurological recovery.
This description comes directly from the study's public registry record.
Jan Claassen, MD · 212-305-7236 · jc1439@cumc.columbia.edu
Angela Velazquez, MD · 212-305-6071 · agv2113@cumc.columbia.edu
Always discuss trial participation with your own doctor first.
| University of Miami and Jackson Health System (UM/JHS) | Miami, Florida, United States | Recruiting |
| Columbia University Medical Center | New York, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03990558